| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |